Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
33,191,114
-
Share change
-
-2,369,940
-
Total reported value
-
$120,785,861
-
Price per share
-
$3.64
-
Number of holders
-
88
-
Value change
-
-$22,548,882
-
Number of buys
-
50
-
Number of sells
-
37
Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q2 2022
As of 30 Jun 2022,
Kronos Bio, Inc. - Common Stock (KRON) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,191,114 shares.
The largest 10 holders included
Omega Fund Management, LLC, Vida Ventures Advisors, LLC, JPMORGAN CHASE & CO, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Artal Group S.A., FMR LLC, Nextech Invest AG, Wildcat Capital Management, LLC, and Alphabet Inc..
This page lists
88
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.